[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

NO3004082T3 - - Google Patents

Info

Publication number
NO3004082T3
NO3004082T3 NO14730591A NO14730591A NO3004082T3 NO 3004082 T3 NO3004082 T3 NO 3004082T3 NO 14730591 A NO14730591 A NO 14730591A NO 14730591 A NO14730591 A NO 14730591A NO 3004082 T3 NO3004082 T3 NO 3004082T3
Authority
NO
Norway
Application number
NO14730591A
Other languages
Norwegian (no)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NO3004082T3 publication Critical patent/NO3004082T3/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/04Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/06Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with the ring nitrogen atom acylated by carboxylic or carbonic acids, or with sulfur or nitrogen analogues thereof, e.g. carbamates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Liquid Crystal Substances (AREA)
NO14730591A 2013-05-30 2014-05-28 NO3004082T3 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IB2013054478 2013-05-30
PCT/IB2014/061774 WO2014191929A1 (en) 2013-05-30 2014-05-28 Cxcr7 receptor modulators

Publications (1)

Publication Number Publication Date
NO3004082T3 true NO3004082T3 (zh) 2017-12-30

Family

ID=50943357

Family Applications (1)

Application Number Title Priority Date Filing Date
NO14730591A NO3004082T3 (zh) 2013-05-30 2014-05-28

Country Status (31)

Country Link
US (1) US9920010B2 (zh)
EP (1) EP3004082B1 (zh)
JP (1) JP6393749B2 (zh)
KR (1) KR102302580B1 (zh)
CN (1) CN105263924B (zh)
AR (1) AR096490A1 (zh)
AU (1) AU2014272718B2 (zh)
BR (1) BR112015030095B1 (zh)
CA (1) CA2912133C (zh)
CL (1) CL2015003470A1 (zh)
CY (1) CY1119537T1 (zh)
DK (1) DK3004082T3 (zh)
EA (1) EA028604B1 (zh)
ES (1) ES2645470T3 (zh)
HK (1) HK1223353A1 (zh)
HR (1) HRP20171597T1 (zh)
HU (1) HUE036649T2 (zh)
IL (1) IL242782B (zh)
LT (1) LT3004082T (zh)
MA (1) MA38679B1 (zh)
MX (1) MX364104B (zh)
MY (1) MY173564A (zh)
NO (1) NO3004082T3 (zh)
PH (1) PH12015502632B1 (zh)
PL (1) PL3004082T3 (zh)
PT (1) PT3004082T (zh)
SG (1) SG11201509057UA (zh)
SI (1) SI3004082T1 (zh)
TW (1) TWI640510B (zh)
UA (1) UA118562C2 (zh)
WO (1) WO2014191929A1 (zh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR091516A1 (es) 2012-06-22 2015-02-11 Actelion Pharmaceuticals Ltd Derivados de 1-[m-carboxamido(hetero)aril-metil]-heterociclil-carboxamida
JP6582056B2 (ja) 2014-12-01 2019-09-25 イドーシア ファーマシューティカルズ リミテッドIdorsia Pharmaceuticals Ltd Cxcr7受容体調節剤
WO2017070431A1 (en) * 2015-10-23 2017-04-27 James Merritt Use of ccr1 antagonists as a treatment for tumors of the central nervous system
WO2018019929A1 (en) 2016-07-28 2018-02-01 Idorsia Pharmaceuticals Ltd Piperidine cxcr7 receptor modulators
CA3060597A1 (en) 2017-05-18 2018-11-22 Idorsia Pharmaceuticals Ltd Phenyl derivatives as pge2 receptor modulators
TW201900178A (zh) 2017-05-18 2019-01-01 瑞士商愛杜西亞製藥有限公司 作為pge2受體調節劑之嘧啶衍生物
HUE066704T2 (hu) 2018-01-26 2024-08-28 Idorsia Pharmaceuticals Ltd CXCR7 receptor antagonista (3S,4S)-1-ciklopropilmetil-4-{[5-(2,4-difluor-fenil)-izoxazol-3-karbonil]-amino} -piperidin-3-karbonsav-(1-pirimidin-2-il-ciklopropil)-amid kristályos formái

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3896170A (en) 1969-02-26 1975-07-22 American Home Prod Intermediates for the preparation of 1,3-dihydro-2h-1, -benzodiazepin-2-ones
EP1071426A2 (en) 1998-02-18 2001-01-31 Neurosearch A/S Novel compounds and their use as positive ampa receptor modulators
GB9816984D0 (en) * 1998-08-05 1998-09-30 Smithkline Beecham Plc Novel compounds
WO2002046164A1 (en) 2000-12-07 2002-06-13 Astrazeneca Ab Therapeutic compounds
DE60327106D1 (de) * 2002-12-20 2009-05-20 Chemocentryx Inc Inhibitoren der bindungder chemokine i-tac bzw. sdf-1 an den ccxckr2-rezeptor
EP2314590A1 (en) * 2005-11-10 2011-04-27 ChemoCentryx, Inc. Substituted quinolones and methods of use
WO2009076404A1 (en) 2007-12-10 2009-06-18 Epix Delaware, Inc. Carboxamide compounds and their use as antagonists of the chemokine ccr2 receptor
AR091516A1 (es) * 2012-06-22 2015-02-11 Actelion Pharmaceuticals Ltd Derivados de 1-[m-carboxamido(hetero)aril-metil]-heterociclil-carboxamida
JP6582056B2 (ja) 2014-12-01 2019-09-25 イドーシア ファーマシューティカルズ リミテッドIdorsia Pharmaceuticals Ltd Cxcr7受容体調節剤

Also Published As

Publication number Publication date
IL242782B (en) 2019-06-30
PL3004082T3 (pl) 2018-01-31
PT3004082T (pt) 2017-11-13
HUE036649T2 (hu) 2018-07-30
EP3004082B1 (en) 2017-08-02
MA38679A1 (fr) 2018-07-31
JP6393749B2 (ja) 2018-09-19
UA118562C2 (uk) 2019-02-11
AR096490A1 (es) 2016-01-13
EP3004082A1 (en) 2016-04-13
IL242782A0 (en) 2016-02-01
CN105263924B (zh) 2018-10-19
BR112015030095B1 (pt) 2023-02-28
NZ715530A (en) 2020-12-18
LT3004082T (lt) 2017-10-25
US20160107997A1 (en) 2016-04-21
SI3004082T1 (sl) 2017-11-30
PH12015502632A1 (en) 2016-03-07
CL2015003470A1 (es) 2016-06-17
CN105263924A (zh) 2016-01-20
US9920010B2 (en) 2018-03-20
TWI640510B (zh) 2018-11-11
CA2912133A1 (en) 2014-12-04
KR102302580B1 (ko) 2021-09-15
HRP20171597T1 (hr) 2017-12-01
WO2014191929A1 (en) 2014-12-04
EA201501163A1 (ru) 2016-06-30
SG11201509057UA (en) 2015-12-30
CA2912133C (en) 2021-06-22
MA38679B1 (fr) 2019-12-31
ES2645470T3 (es) 2017-12-05
PH12015502632B1 (en) 2016-03-07
MY173564A (en) 2020-02-04
DK3004082T3 (en) 2017-10-02
AU2014272718B2 (en) 2018-06-28
MX364104B (es) 2019-04-12
AU2014272718A1 (en) 2016-01-21
KR20160013197A (ko) 2016-02-03
JP2016520120A (ja) 2016-07-11
MX2015016429A (es) 2016-03-01
EA028604B1 (ru) 2017-12-29
BR112015030095A2 (pt) 2022-07-12
CY1119537T1 (el) 2018-03-07
TW201529557A (zh) 2015-08-01
HK1223353A1 (zh) 2017-07-28

Similar Documents

Publication Publication Date Title
AP2016009275A0 (zh)
BR112015007533A2 (zh)
BR102016010778A2 (zh)
BR112014018502A2 (zh)
BR112014019326A2 (zh)
BR112014018516A2 (zh)
BR112014020341A2 (zh)
BR112014018480A2 (zh)
BR112014017669A2 (zh)
BR112014021878A2 (zh)
BR112014018468A2 (zh)
BR112016005824A2 (zh)
BR112014019204A2 (zh)
BR112016001437A2 (zh)
BR112014017722A2 (zh)
BR112015015948A2 (zh)
BR112014018578A2 (zh)
BR112014018483A2 (zh)
BR112014017794A2 (zh)
BR112014017653A2 (zh)
BR112016009017A2 (zh)
BR112014017601A2 (zh)
BR112015015312A2 (zh)
BR112014018353A2 (zh)
BR112014018496A2 (zh)